Amedisys Inc (AMED) 25.22 $AMED
Nasdaq stocks posting largest percentage increases
AP - 2 hrs 29 mins ago
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
IMDZ: 30.68 (+2.90), KONA: 21.55 (+2.17), BGFV: 12.03 (+1.23), RDCM: 8.95 (+2.74), TQNT: 20.20 (+1.77), AMED: 25.22 (+3.46), MRCY: 13.72 (+1.55)
Amedisys beats Street 3Q forecasts
Automated Insights - Wed Oct 29, 9:07AM CDT
BATON ROUGE, La. (AP) _ Amedisys Inc. (AMED) on Wednesday reported net income of $8.4 million in its third quarter.
AMED: 25.22 (+3.46)
Amedisys Reports Third Quarter Financial Results
GlobeNewswire - Wed Oct 29, 6:00AM CDT
Amedisys, Inc. (Nasdaq:AMED), a leading home health and hospice company, today reported its financial results for the three and nine-month periods ended September 30, 2014.
AMED: 25.22 (+3.46)
35.6% Return Seen to Date on SmarTrend Amedisys Call (AMED)
Comtex SmarTrend(R) - Tue Oct 28, 9:12AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 4 months, Amedisys has returned 35.58% as of today's recent price of $21.70.
AMED: 25.22 (+3.46)
5 Stocks Set to Soar on Bullish Earnings
at The Street - Mon Oct 27, 12:00PM CDT
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
KN: 19.22 (-0.18), RYAM: 28.39 (-1.94), CLF: 10.22 (-1.07), AMED: 25.22 (+3.46), LOCK: 15.31 (-0.79)
Quest Diagnostics Beats on Earnings & Revs, Ups View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 12:15PM CDT
Quest Diagnostics' (DGX) third-quarter 2014 adjusted earnings per share (EPS) from continuing operations came in at $1.10.
DGX: 63.68 (-0.06), AMED: 25.22 (+3.46), HLS: 39.30 (+0.10), GTIV: 19.55 (-0.03)
Uptrend Call Working As Amedisys Stock Rises 34.8% (AMED)
Comtex SmarTrend(R) - Mon Oct 20, 4:51PM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.00. In approximately 4 months, Amedisys has returned 34.83% as of today's recent price of $21.58.
AMED: 25.22 (+3.46)
Amedisys Announces Third Quarter Earnings Release and Conference Call Date
GlobeNewswire - Thu Oct 16, 4:46PM CDT
Amedisys, Inc. (Nasdaq:AMED), one of America's leading home health and hospice care companies, announced today that it will host a conference call to discuss results for the third quarter ended September 30, 2014 on Wednesday, October 29, 2014 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The Company will issue its quarterly earnings release prior to hosting the conference call.
AMED: 25.22 (+3.46)
Amedisys Has Returned 25.9% Since SmarTrend Recommendation (AMED)
Comtex SmarTrend(R) - Mon Oct 13, 11:00AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.00. In approximately 4 months, Amedisys has returned 25.90% as of today's recent price of $20.15.
AMED: 25.22 (+3.46)
Gentiva Awaits Acquisition; Inorganic Growth Compelling - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 8:50AM CDT
On Oct 10, 2014, we issued an updated research report on Gentiva Health Services, Inc. (GTIV).
KND: 21.22 (+0.16), AMED: 25.22 (+3.46), HLS: 39.30 (+0.10), GTIV: 19.55 (-0.03)
Gentiva Health Services (GTIV) Soars: Stock Rises 16.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 7:51AM CDT
Gentiva Health Services Inc. (GTIV) was a big mover last session, as the company shares rose almost 17% on the day.
USPH: 42.15 (+0.78), AFAM: 28.68 (+0.64), AMED: 25.22 (+3.46), GTIV: 19.55 (-0.03)
Walgreens' (WAG) September Sales Impress, Up 9.4% Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 06, 1:50PM CDT
Walgreen Co. (WAG) recently reported results for the month of Sep 2014.
ABAX: 49.64 (-0.37), CVS: 85.19 (-0.01), AMED: 25.22 (+3.46), WAG: 62.83 (-0.87)
Shares of AMED Up 27.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Sep 29, 9:11AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 3 months, Amedisys has returned 27.52% as of today's recent price of $20.41.
AMED: 25.22 (+3.46)
Should Amedisys (AMED) Be in Your Portfolio Post Q2? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 2:10PM CDT
On Sep 19, Zacks Investment Research upgraded Amedisys Inc. (AMED) to a Zacks Rank #1 (Strong Buy).
AFAM: 28.68 (+0.64), AMED: 25.22 (+3.46), HLS: 39.30 (+0.10), GTIV: 19.55 (-0.03)
AmSurg Upbeat About Sheridan Acquisition Despite Poor Q2 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 23, 5:25PM CDT
On Sep 23, we issued an updated research report on AmSurg Corporation (AMSG) -- a leading operator of single-specialty practice-based ambulatory surgery centers (ASCs).
AMSG: 51.58 (+0.20), AMED: 25.22 (+3.46), HLS: 39.30 (+0.10), GTIV: 19.55 (-0.03)
Five Star Quality Care (FVE) in Focus: Stock Gains 12.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Sep 23, 8:25AM CDT
Five Star Quality Care (FVE) was a big mover last session, with shares rising over 12% on the day.
FVE: 4.03 (+0.02), AFAM: 28.68 (+0.64), AMED: 25.22 (+3.46), HLS: 39.30 (+0.10)
Uptrend Call Working As Amedisys Stock Rises 26.9% (AMED)
Comtex SmarTrend(R) - Fri Sep 19, 4:49PM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 3 months, Amedisys has returned 26.90% as of today's recent price of $20.31.
AMED: 25.22 (+3.46)
Nasdaq stocks posting largest percentage increases
AP - 2 hrs 29 mins ago
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
IMDZ: 30.68 (+2.90), KONA: 21.55 (+2.17), BGFV: 12.03 (+1.23), RDCM: 8.95 (+2.74), TQNT: 20.20 (+1.77), AMED: 25.22 (+3.46), MRCY: 13.72 (+1.55)
Amedisys beats Street 3Q forecasts
Automated Insights - Wed Oct 29, 9:07AM CDT
BATON ROUGE, La. (AP) _ Amedisys Inc. (AMED) on Wednesday reported net income of $8.4 million in its third quarter.
AMED: 25.22 (+3.46)
Amedisys Reports Third Quarter Financial Results
GlobeNewswire - Wed Oct 29, 6:00AM CDT
Amedisys, Inc. (Nasdaq:AMED), a leading home health and hospice company, today reported its financial results for the three and nine-month periods ended September 30, 2014.
AMED: 25.22 (+3.46)
35.6% Return Seen to Date on SmarTrend Amedisys Call (AMED)
Comtex SmarTrend(R) - Tue Oct 28, 9:12AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 4 months, Amedisys has returned 35.58% as of today's recent price of $21.70.
AMED: 25.22 (+3.46)
5 Stocks Set to Soar on Bullish Earnings
at The Street - Mon Oct 27, 12:00PM CDT
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
KN: 19.22 (-0.18), RYAM: 28.39 (-1.94), CLF: 10.22 (-1.07), AMED: 25.22 (+3.46), LOCK: 15.31 (-0.79)
Quest Diagnostics Beats on Earnings & Revs, Ups View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 12:15PM CDT
Quest Diagnostics' (DGX) third-quarter 2014 adjusted earnings per share (EPS) from continuing operations came in at $1.10.
DGX: 63.68 (-0.06), AMED: 25.22 (+3.46), HLS: 39.30 (+0.10), GTIV: 19.55 (-0.03)
Uptrend Call Working As Amedisys Stock Rises 34.8% (AMED)
Comtex SmarTrend(R) - Mon Oct 20, 4:51PM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.00. In approximately 4 months, Amedisys has returned 34.83% as of today's recent price of $21.58.
AMED: 25.22 (+3.46)
Amedisys Announces Third Quarter Earnings Release and Conference Call Date
GlobeNewswire - Thu Oct 16, 4:46PM CDT
Amedisys, Inc. (Nasdaq:AMED), one of America's leading home health and hospice care companies, announced today that it will host a conference call to discuss results for the third quarter ended September 30, 2014 on Wednesday, October 29, 2014 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The Company will issue its quarterly earnings release prior to hosting the conference call.
AMED: 25.22 (+3.46)
Amedisys Has Returned 25.9% Since SmarTrend Recommendation (AMED)
Comtex SmarTrend(R) - Mon Oct 13, 11:00AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.00. In approximately 4 months, Amedisys has returned 25.90% as of today's recent price of $20.15.
AMED: 25.22 (+3.46)
Gentiva Awaits Acquisition; Inorganic Growth Compelling - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 8:50AM CDT
On Oct 10, 2014, we issued an updated research report on Gentiva Health Services, Inc. (GTIV).
KND: 21.22 (+0.16), AMED: 25.22 (+3.46), HLS: 39.30 (+0.10), GTIV: 19.55 (-0.03)
Gentiva Health Services (GTIV) Soars: Stock Rises 16.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 7:51AM CDT
Gentiva Health Services Inc. (GTIV) was a big mover last session, as the company shares rose almost 17% on the day.
USPH: 42.15 (+0.78), AFAM: 28.68 (+0.64), AMED: 25.22 (+3.46), GTIV: 19.55 (-0.03)
Walgreens' (WAG) September Sales Impress, Up 9.4% Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 06, 1:50PM CDT
Walgreen Co. (WAG) recently reported results for the month of Sep 2014.
ABAX: 49.64 (-0.37), CVS: 85.19 (-0.01), AMED: 25.22 (+3.46), WAG: 62.83 (-0.87)
Shares of AMED Up 27.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Sep 29, 9:11AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 3 months, Amedisys has returned 27.52% as of today's recent price of $20.41.
AMED: 25.22 (+3.46)
Should Amedisys (AMED) Be in Your Portfolio Post Q2? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 2:10PM CDT
On Sep 19, Zacks Investment Research upgraded Amedisys Inc. (AMED) to a Zacks Rank #1 (Strong Buy).
AFAM: 28.68 (+0.64), AMED: 25.22 (+3.46), HLS: 39.30 (+0.10), GTIV: 19.55 (-0.03)
AmSurg Upbeat About Sheridan Acquisition Despite Poor Q2 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 23, 5:25PM CDT
On Sep 23, we issued an updated research report on AmSurg Corporation (AMSG) -- a leading operator of single-specialty practice-based ambulatory surgery centers (ASCs).
AMSG: 51.58 (+0.20), AMED: 25.22 (+3.46), HLS: 39.30 (+0.10), GTIV: 19.55 (-0.03)
Five Star Quality Care (FVE) in Focus: Stock Gains 12.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Sep 23, 8:25AM CDT
Five Star Quality Care (FVE) was a big mover last session, with shares rising over 12% on the day.
FVE: 4.03 (+0.02), AFAM: 28.68 (+0.64), AMED: 25.22 (+3.46), HLS: 39.30 (+0.10)
Uptrend Call Working As Amedisys Stock Rises 26.9% (AMED)
Comtex SmarTrend(R) - Fri Sep 19, 4:49PM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 3 months, Amedisys has returned 26.90% as of today's recent price of $20.31.
AMED: 25.22 (+3.46)
